Predictive effect of five hepatitis B virus markers on re-vaccination time of hepatitis B vaccine

  • Authors:
    • Qiuhua Jia
    • Fei Yu
    • Qi Zhou
    • Xiaoyan Chen
    • Zhaoqi Gu
    • Chunling Ma
  • View Affiliations

  • Published online on: June 10, 2020     https://doi.org/10.3892/etm.2020.8859
  • Pages: 1709-1715
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Examination of predictive effect of five hepatitis B virus (HBV) markers on the re-vaccination time of hepatitis B vaccine was assessed. A total of 3,243 patients examined by five HBV markers in Women and Children's Health Care Hospital of Linyi from January 2015 to December 2017 were selected as the subjects and analyzed retrospectively. According to the previous time of hepatitis B antibody vaccination, subjects were divided into three groups: Short-term group (previous time of hepatitis B vaccination <5 years, n=798); medium-term group (>5 years - ≤10 years, n=1,242); long‑term group (>10 years, n=1,203). The enzyme linked immunosorbent assay was used to qualitatively analyze the five HBV markers, and chemiluminescence immunoassay was used to quantitatively analyze the five HBV markers. Hepatitis B surface antigen (HBsAg) in the long-term group and the medium-term group was significantly lower than that in the short-term group (P<0.001). HBsAg, hepatitis B e antigen, hepatitis B e antibody, hepatitis B core antibody in the long-term group was significantly higher than that in the medium-term and short-term group (P<0.050). The hepatitis B surface antibody in the long-term group was significantly lower than that in the other two groups (P<0.050). According to the previous time of the hepatitis B antibody vaccination, the patients in the long-term group were subdivided into three groups: Group A (vaccination time: 10-13 years, n=420); group B (13-15 years, n=377) and group C (>15 years, n=406). Geometric mean titer in group A was significantly lower than that in the other two groups (P<0.050). In conclusion, the protective effect of hepatitis B antibody vaccine is satisfactory for 10 years after vaccination, and re-vaccination is recommended after more than 13 years of vaccination when the virus begins to increase significantly, in order to prevent the occurrence of hepatitis B.

Related Articles

Journal Cover

August-2020
Volume 20 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Jia, Q., Yu, F., Zhou, Q., Chen, X., Gu, Z., & Ma, C. (2020). Predictive effect of five hepatitis B virus markers on re-vaccination time of hepatitis B vaccine. Experimental and Therapeutic Medicine, 20, 1709-1715. https://doi.org/10.3892/etm.2020.8859
MLA
Jia, Q., Yu, F., Zhou, Q., Chen, X., Gu, Z., Ma, C."Predictive effect of five hepatitis B virus markers on re-vaccination time of hepatitis B vaccine". Experimental and Therapeutic Medicine 20.2 (2020): 1709-1715.
Chicago
Jia, Q., Yu, F., Zhou, Q., Chen, X., Gu, Z., Ma, C."Predictive effect of five hepatitis B virus markers on re-vaccination time of hepatitis B vaccine". Experimental and Therapeutic Medicine 20, no. 2 (2020): 1709-1715. https://doi.org/10.3892/etm.2020.8859